Pediatric Multicenter Study of REPEL-CV

This study is currently recruiting participants.

Verified by SyntheMed, June 2005

Sponsored by:	SyntheMed
Information provided by:	SyntheMed
ClinicalTrials.gov Identifier:	NCT00116233

Purpose

This trial will study REPEL-CV for reducing post operative adhesions following cardiovascular (cv) surgery.

Condition	Intervention	Phase
Adhesions	Device: REPEL-CV	Phase II

MedlinePlus related topics: Adhesions

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title:	Peds. Multicenter Study

Further study details as provided by SyntheMed:

Detailed Description:

- Efficacy at second sternotomy

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00116233

Contacts

Contact: Eli Pines, Ph.D.

212-460-9488

Locations

United States, New Jersey
SyntheMed	Recruiting
Little Silver, New Jersey, United States, 07739
Contact: Eli Pines, Ph.D. 212-460-9488

Sponsors and Collaborators

SyntheMed

Investigators

Study Director:

Eli Pines

SyntheMed

More Information

Study ID Numbers:	LMS0104RCV
Study First Received:	June 27, 2005
Last Updated:	June 27, 2005
ClinicalTrials.gov Identifier:	NCT00116233
Health Authority:	United States: Food and Drug Administration

Keywords provided by SyntheMed:

post operative adhesions

Study placed in the following topic categories:

Adhesions

Additional relevant MeSH terms:

Pathologic Processes

ClinicalTrials.gov processed this record on January 14, 2009